JAK2 and Burkitt lymphoma: The selective JAK2 inhibitor TG101209 induced cell differentiation, apoptosis, and G2/M cell cycle arrest in Raji and Ramos Burkitt lymphoma cells by downregulation of MYB upon inhibition of JAK2/STAT3 signaling.